Filing Manager
Oyster Enterprises II LLC
Reporting Manager
Oyster Enterprises II LLC
Symbol
OYSE
Shares outstanding
33,851,215 shares
Disclosed Ownership
8,361,250 shares
Ownership
25%
Form type
SCHEDULE 13D
Filing time
02 Jun 2025, 06:23:38 UTC
Date of event
23 May 2025

Quoteable Key Fact

"Oyster Enterprises II LLC disclosed 25% ownership in Oyster Enterprises II Acquisition Corp Class A Ordinary Shares, $0.0001 par value (OYSE) on 23 May 2025."

Quick Takeaways

  • Oyster Enterprises II LLC filed SCHEDULE 13D for Oyster Enterprises II Acquisition Corp Class A Ordinary Shares, $0.0001 par value (OYSE).
  • Disclosed ownership: 25%.
  • Date of event: 23 May 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 02 Jun 2025, 06:23.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Oyster Enterprises II LLC 25% 8,361,250 8,361,250 0 /s/ Oyster Management II LLC managing member of Oyster Enterprises II LLC by Mario Zarazua, an authorized signatory 0002046100
Oyster Management II LLC 25% 8,361,250 0 8,361,250 /s/ Mario Zarazua by Mario Zarazua, an authorized signatory 0002046108
Mario Zarazua 25% 8,361,250 0 8,361,250 /s/ Mario Zarazua Mario Zarazua 0002046099
Heath Freeman 25% 8,361,250 0 8,361,250 /s/ Heath Freeman Heath Freeman 0001693074
Randall D. Smith 25% 8,361,250 0 8,361,250 /s/ Randall Smith Randall Smith 0001016345
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .